Cargando…
Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
IMPORTANCE: The recent development of targeted therapy and immunotherapy has made neoadjuvant therapy an attractive option for patients with hepatocellular carcinoma (HCC). However, surgeons are concerned that adverse effects of neoadjuvant therapy with these agents could lead to delayed or even can...
Autores principales: | Griffiths, Christopher D., Zhang, Betty, Tywonek, Kasia, Meyers, Brandon M., Serrano, Pablo E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295000/ https://www.ncbi.nlm.nih.gov/pubmed/35849393 http://dx.doi.org/10.1001/jamanetworkopen.2022.22721 |
Ejemplares similares
-
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Xie, Enrui, et al.
Publicado: (2023) -
Radiologic Response Combined with Dermatologic Toxicities is the Most Robust Predictor of Survival Benefits in Patients with Inoperable Hepatocellular Carcinoma After Transarterial Chemoembolization Plus Sorafenib Therapy
por: Ye, Zhiqiu, et al.
Publicado: (2021) -
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy
por: Li, Xingzhe, et al.
Publicado: (2021) -
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy
por: Youssef, Irini, et al.
Publicado: (2022) -
Financial Toxicity Among Patients With Breast Cancer Worldwide: A Systematic Review and Meta-analysis
por: Ehsan, Anam N., et al.
Publicado: (2023)